Toll Free: 1-888-928-9744

Global and United States Inactivated Vaccine In-Depth Research Report 2017-2022

Published: Aug 9, 2017 | Pages: 107 | Publisher: US Market Insight (UMI) | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Inactivated Vaccine industry.

Major Companies

•	Astellas Pharma (Japan)
•	CSL Limited (Australia)
•	Emergent BioSolutions (U.S.)
•	GlaxoSmithKline (U.K.)
•	Johnson & Johnson (U.S.)
•	MedImmune (U.S.)
•	Merck & Co (U.S.)
•	Pfizer (U.S.)
•	Sanofi Pasteur (France)
•	Serum Institute of India Pvt (India)

Key Regions

•	North America
•	United States
•	California
•	Texas
•	New York
•	Others
•	Canada
•	Latin America
•	Mexico
•	Brazil
•	Argentina
•	Others
•	Europe
•	Germany
•	United Kingdom
•	France
•	Italy
•	Spain
•	Russia
•	Netherland
•	Others
•	Asia & Pacific
•	China
•	Japan
•	India
•	Korea
•	Australia
•	Southeast Asia
•	Indonesia
•	Thailand
•	Philippines
•	Vietnam
•	Singapore
•	Malaysia
•	Others
•	Africa & Middle East
•	South Africa
•	Egypt
•	Turkey
•	Saudi Arabia
•	Iran
•	Others

Main types of products

Inactivated Vaccine Market, by End User

•	Pediatrics
•	Adults

Inactivated Vaccine Market, by Disease Indication

•	Pneumococcal
•	Influenza
•	HPV
•	Hepatitis
•	Rotavirus

Inactivated Vaccine Market, by Key Consumers

•	Hospital
•	Medical Center
 Table of Contents

Global and United States Inactivated Vaccine In-Depth Research Report 2017-2022

Chapter One Global Inactivated Vaccine Market Overview
    1.1 Global Inactivated Vaccine Market Sales Volume Revenue and Price 2012-2017
    1.2 Inactivated Vaccine, by End User 2012-2017
        1.2.1 Global Inactivated Vaccine Sales Market Share by End User 2012-2017
        1.2.2 Global Inactivated Vaccine Revenue Market Share by End User 2012-2017
        1.2.3 Global Inactivated Vaccine Price by End User 2012-2017
        1.2.4 Pediatrics
        1.2.5 Adults
    1.3 Inactivated Vaccine, by Disease Indication 2012-2017
        1.3.1 Global Inactivated Vaccine Sales Market Share by Disease Indication 2012-2017
        1.3.2 Global Inactivated Vaccine Revenue Market Share by Disease Indication 2012-2017
        1.3.3 Global Inactivated Vaccine Price by Disease Indication 2012-2017
        1.3.4 Pneumococcal
        1.3.5 Influenza
        1.3.6 HPV
        1.3.7 Hepatitis
        1.3.8 Rotavirus

Chapter Two United States Inactivated Vaccine Market Overview
    2.1 United States Inactivated Vaccine Market Sales Volume Revenue and Price 2012-2017
    2.2 Inactivated Vaccine, by End User 2012-2017
        2.2.1 United States Inactivated Vaccine Sales Market Share by End User 2012-2017
        2.2.2 United States Inactivated Vaccine Revenue Market Share by End User 2012-2017
        2.2.3 United States Inactivated Vaccine Price by End User 2012-2017
        2.2.4 Pediatrics
        2.2.5 Adults
    2.3 Inactivated Vaccine, by Disease Indication 2012-2017
        2.3.1 United States Inactivated Vaccine Sales Market Share by Disease Indication 2012-2017
        2.3.2 United States Inactivated Vaccine Revenue Market Share by Disease Indication 2012-2017
        2.3.3 United States Inactivated Vaccine Price by Disease Indication 2012-2017
        2.3.4 Pneumococcal
        2.3.5 Influenza
        2.3.6 HPV
        2.3.7 Hepatitis
        2.3.8 Rotavirus

Chapter Three Inactivated Vaccine by Regions 2012-2017
    3.1 Global Inactivated Vaccine Sales Market Share by Regions 2012-2017
    3.2 Global Inactivated Vaccine Revenue Market Share by Regions 2012-2017
    3.3 Global Inactivated Vaccine Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Inactivated Vaccine by Companies 2012-2017
    4.1 Global Inactivated Vaccine Sales Volume Market Share by Companies 2012-2017
    4.2 Global Inactivated Vaccine Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Inactivated Vaccine Key Product Model and Market Performance
    4.4 Global Top Companies Inactivated Vaccine Key Target Consumers and Market Performance

Chapter Five United States Inactivated Vaccine by Companies 2012-2017
    5.1 United States Inactivated Vaccine Sales Volume Market Share by Companies 2012-2017
    5.2 United States Inactivated Vaccine Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Inactivated Vaccine Key Product Model and Market Performance
    5.4 United States Top Companies Inactivated Vaccine Key Target Consumers and Market Performance

Chapter Six Global Inactivated Vaccine by Consumer 2012-2017
    6.1 Global Inactivated Vaccine Sales Market Share by Consumer 2012-2017
    6.2 Hospital
    6.3 Medical Center
    6.4 Consuming Habit and Preference

Chapter Seven Global Inactivated Vaccine by Consumer 2012-2017
    7.1 Global Inactivated Vaccine Sales Market Share by Consumer 2012-2017
    7.2 Hospital
    7.3 Medical Center
    7.4 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 Astellas Pharma (Japan)
        8.1.1 Astellas Pharma (Japan) Company Details and Competitors
        8.1.2 Astellas Pharma (Japan) Key Inactivated Vaccine Models and Performance
        8.1.3 Astellas Pharma (Japan) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.1.4 Astellas Pharma (Japan) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.2 CSL Limited (Australia)
        8.2.1 CSL Limited (Australia) Company Details and Competitors
        8.2.2 CSL Limited (Australia) Key Inactivated Vaccine Models and Performance
        8.2.3 CSL Limited (Australia) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.2.4 CSL Limited (Australia) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.3 Emergent BioSolutions (U.S.)
        8.3.1 Emergent BioSolutions (U.S.) Company Details and Competitors
        8.3.2 Emergent BioSolutions (U.S.) Key Inactivated Vaccine Models and Performance
        8.3.3 Emergent BioSolutions (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.3.4 Emergent BioSolutions (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.4 GlaxoSmithKline (U.K.)
        8.4.1 GlaxoSmithKline (U.K.) Company Details and Competitors
        8.4.2 GlaxoSmithKline (U.K.) Key Inactivated Vaccine Models and Performance
        8.4.3 GlaxoSmithKline (U.K.) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.4.4 GlaxoSmithKline (U.K.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.5 Johnson & Johnson (U.S.)
        8.5.1 Johnson & Johnson (U.S.) Company Details and Competitors
        8.5.2 Johnson & Johnson (U.S.) Key Inactivated Vaccine Models and Performance
        8.5.3 Johnson & Johnson (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.5.4 Johnson & Johnson (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.6 MedImmune (U.S.)
        8.6.1 MedImmune (U.S.) Company Details and Competitors
        8.6.2 MedImmune (U.S.) Key Inactivated Vaccine Models and Performance
        8.6.3 MedImmune (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.6.4 MedImmune (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.7 Merck & Co (U.S.)
        8.7.1 Merck & Co (U.S.) Company Details and Competitors
        8.7.2 Merck & Co (U.S.) Key Inactivated Vaccine Models and Performance
        8.7.3 Merck & Co (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.7.4 Merck & Co (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.8 Pfizer (U.S.)
        8.8.1 Pfizer (U.S.) Company Details and Competitors
        8.8.2 Pfizer (U.S.) Key Inactivated Vaccine Models and Performance
        8.8.3 Pfizer (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.8.4 Pfizer (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.9 Sanofi Pasteur (France)
        8.9.1 Sanofi Pasteur (France) Company Details and Competitors
        8.9.2 Sanofi Pasteur (France) Key Inactivated Vaccine Models and Performance
        8.9.3 Sanofi Pasteur (France) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.9.4 Sanofi Pasteur (France) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    8.10 Serum Institute of India Pvt (India)
        8.10.1 Serum Institute of India Pvt (India) Company Details and Competitors
        8.10.2 Serum Institute of India Pvt (India) Key Inactivated Vaccine Models and Performance
        8.10.3 Serum Institute of India Pvt (India) Inactivated Vaccine Business SWOT Analysis and Forecast
        8.10.4 Serum Institute of India Pvt (India) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin

Chapter Nine Industry Chain and Supply Chain
    9.1 Inactivated Vaccine Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Inactivated Vaccine Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Inactivated Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Inactivated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Inactivated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    10.3 Global Inactivated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    10.4 Global Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    10.5 Global Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)

Chapter Eleven United States Inactivated Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Inactivated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Inactivated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    11.3 United States Inactivated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 United States Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    11.5 United States Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
List of Tables and Figures

    Table Global Inactivated Vaccine Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Inactivated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Inactivated Vaccine Sales (K Pcs) by End User (2012-2017)
    Table Global Inactivated Vaccine Sales Market Share by End User (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by End User in 2016
    Table Global Inactivated Vaccine Revenue (Million USD) by End User (2012-2017)
    Table Global Inactivated Vaccine Revenue Market Share by End User (2012-2017)
    Figure Global Inactivated Vaccine Revenue Market Share by End User in 2016
    Table Global Inactivated Vaccine Price (USD/Pcs) by End User (2012-2017)
    Table Top Companies of Pediatrics Inactivated Vaccine Products List
    Figure Global Pediatrics Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Adults Inactivated Vaccine Products List
    Figure Global Adults Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Inactivated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
    Table Global Inactivated Vaccine Sales Market Share by Disease Indication (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by Disease Indication in 2016
    Table Global Inactivated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
    Table Global Inactivated Vaccine Revenue Market Share by Disease Indication (2012-2017)
    Figure Global Inactivated Vaccine Revenue Market Share by Disease Indication in 2016
    Table Global Inactivated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
    Table Top Companies of Pneumococcal Inactivated Vaccine Products List
    Figure Global Pneumococcal Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Influenza Inactivated Vaccine Products List
    Figure Global Influenza Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of HPV Inactivated Vaccine Products List
    Figure Global HPV Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Hepatitis Inactivated Vaccine Products List
    Figure Global Hepatitis Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Rotavirus Inactivated Vaccine Products List
    Figure Global Rotavirus Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Inactivated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table United States Inactivated Vaccine Sales (K Pcs) by End User (2012-2017)
    Table United States Inactivated Vaccine Sales Market Share by End User (2012-2017)
    Figure United States Inactivated Vaccine Sales Market Share by End User in 2016
    Table United States Inactivated Vaccine Revenue (Million USD) by End User (2012-2017)
    Table United States Inactivated Vaccine Revenue Market Share by End User (2012-2017)
    Figure United States Inactivated Vaccine Revenue Market Share by End User in 2016
    Table United States Inactivated Vaccine Price (USD/Pcs) by End User (2012-2017)
    Table Top Companies of Pediatrics Inactivated Vaccine Products List
    Figure United States Pediatrics Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Adults Inactivated Vaccine Products List
    Figure United States Adults Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Inactivated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
    Table United States Inactivated Vaccine Sales Market Share by Disease Indication (2012-2017)
    Figure United States Inactivated Vaccine Sales Market Share by Disease Indication in 2016
    Table United States Inactivated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
    Table United States Inactivated Vaccine Revenue Market Share by Disease Indication (2012-2017)
    Figure United States Inactivated Vaccine Revenue Market Share by Disease Indication in 2016
    Table United States Inactivated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
    Table Top Companies of Pneumococcal Inactivated Vaccine Products List
    Figure United States Pneumococcal Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Influenza Inactivated Vaccine Products List
    Figure United States Influenza Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of HPV Inactivated Vaccine Products List
    Figure United States HPV Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Hepatitis Inactivated Vaccine Products List
    Figure United States Hepatitis Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Companies of Rotavirus Inactivated Vaccine Products List
    Figure United States Rotavirus Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Global Inactivated Vaccine Sales Share by Regions (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by Regions in 2016
    Figure Global Inactivated Vaccine Sales Market Share by Regions in 2017
    Table Global Inactivated Vaccine Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Inactivated Vaccine Revenue Market Share by Regions (2012-2017)
    Figure Global Inactivated Vaccine Revenue Market Share by Regions in 2016
    Figure Global Inactivated Vaccine Revenue Market Share by Regions in 2017
    Table Global Inactivated Vaccine Price (USD/Pcs) by Regions (2012-2017)
    Table North America Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table North America Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure North America Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table United States Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure United States Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Europe Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Inactivated Vaccine Sales Volume (K Pcs) by Major Companies (2012-2017)
    Table Global Inactivated Vaccine Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Inactivated Vaccine Sales Volume Market Share by Major Companies 2016
    Figure Global Inactivated Vaccine Sales Volume Market Share by Major Companies 2017
    Table Global Inactivated Vaccine Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Inactivated Vaccine Revenue Market Share by Major Companies (2012-2017)
    Figure Global Inactivated Vaccine Revenue Market Share by Major Companies 2016
    Figure Global Inactivated Vaccine Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Inactivated Vaccine Sales Volume (K Pcs) by Top Companies (2012-2017)
    Table United States Inactivated Vaccine Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Inactivated Vaccine Sales Volume Market Share by Top Companies 2016
    Figure United States Inactivated Vaccine Sales Volume Market Share by Top Companies 2017
    Table United States Inactivated Vaccine Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Inactivated Vaccine Revenue Market Share by Top Companies (2012-2017)
    Figure United States Inactivated Vaccine Revenue Market Share by Top Companies 2016
    Figure United States Inactivated Vaccine Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Inactivated Vaccine Sales (K Pcs) by Consumer (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by Consumer (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by Consumer in 2016
    Figure Global Hospital Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Medical Center Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Inactivated Vaccine Sales (K Pcs) by Consumer (2012-2017)
    Figure United States Inactivated Vaccine Sales Market Share by Consumer (2012-2017)
    Figure United States Inactivated Vaccine Sales Market Share by Consumer in 2016
    Figure United States Hospital Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Medical Center Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Astellas Pharma (Japan) Company Details and Competitors
    Table Astellas Pharma (Japan) Key Inactivated Vaccine Models and Performance
    Table Astellas Pharma (Japan) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Astellas Pharma (Japan) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Astellas Pharma (Japan) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Astellas Pharma (Japan) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Astellas Pharma (Japan) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Astellas Pharma (Japan) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table CSL Limited (Australia) Company Details and Competitors
    Table CSL Limited (Australia) Key Inactivated Vaccine Models and Performance
    Table CSL Limited (Australia) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table CSL Limited (Australia) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure CSL Limited (Australia) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure CSL Limited (Australia) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure CSL Limited (Australia) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure CSL Limited (Australia) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Emergent BioSolutions (U.S.) Company Details and Competitors
    Table Emergent BioSolutions (U.S.) Key Inactivated Vaccine Models and Performance
    Table Emergent BioSolutions (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Emergent BioSolutions (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline (U.K.) Company Details and Competitors
    Table GlaxoSmithKline (U.K.) Key Inactivated Vaccine Models and Performance
    Table GlaxoSmithKline (U.K.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table GlaxoSmithKline (U.K.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Johnson & Johnson (U.S.) Company Details and Competitors
    Table Johnson & Johnson (U.S.) Key Inactivated Vaccine Models and Performance
    Table Johnson & Johnson (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Johnson & Johnson (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Johnson & Johnson (U.S.) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table MedImmune (U.S.) Company Details and Competitors
    Table MedImmune (U.S.) Key Inactivated Vaccine Models and Performance
    Table MedImmune (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table MedImmune (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure MedImmune (U.S.) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure MedImmune (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure MedImmune (U.S.) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure MedImmune (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Merck & Co (U.S.) Company Details and Competitors
    Table Merck & Co (U.S.) Key Inactivated Vaccine Models and Performance
    Table Merck & Co (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Merck & Co (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Merck & Co (U.S.) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Merck & Co (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Merck & Co (U.S.) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Merck & Co (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer (U.S.) Company Details and Competitors
    Table Pfizer (U.S.) Key Inactivated Vaccine Models and Performance
    Table Pfizer (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Pfizer (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Pfizer (U.S.) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer (U.S.) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Sanofi Pasteur (France) Company Details and Competitors
    Table Sanofi Pasteur (France) Key Inactivated Vaccine Models and Performance
    Table Sanofi Pasteur (France) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Sanofi Pasteur (France) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Sanofi Pasteur (France) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Sanofi Pasteur (France) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Sanofi Pasteur (France) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Sanofi Pasteur (France) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Serum Institute of India Pvt (India) Company Details and Competitors
    Table Serum Institute of India Pvt (India) Key Inactivated Vaccine Models and Performance
    Table Serum Institute of India Pvt (India) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Serum Institute of India Pvt (India) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Inactivated Vaccine Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Serum Institute of India Pvt (India) Inactivated Vaccine Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Figure Global Inactivated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Inactivated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Inactivated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Inactivated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Share Forecast by Regions in 2022
    Table Global Inactivated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by Application in 2022
    Table Global Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Global Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by End User in 2022
    Table Global Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Global Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by Disease Indication in 2022
    Figure United States Inactivated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure United States Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Inactivated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Inactivated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    Table United States Inactivated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Inactivated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Inactivated Vaccine Sales Volume Share Forecast by Regions in 2022
    Table United States Inactivated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    Figure United States Inactivated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Inactivated Vaccine Sales Volume Market Share Forecast by Application in 2022
    Table United States Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure United States Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure United States Inactivated Vaccine Sales Volume Market Share Forecast by End User in 2022
    Table United States Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure United States Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure United States Inactivated Vaccine Sales Volume Market Share Forecast by Disease Indication in 2022 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expe

Read More...

North America air conditioner market size is expected to be valued at USD 52,560.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing usage of energy efficient air conditioners owing to declining energy consumption rat

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...
Choose License Type
Single User - US $3190
Multi User - US $6380
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify